Previous 10 | Next 10 |
2022 revenue increased 32% YoY to $2.05 million, while gross profit margin improved As of December 31, 2022, had over $6.6 million in cash and securities which is sufficient to operate through 2025 LANGHORNE, Pa., March 27, 2023 (GLOBE NEWSWIRE) -- NEXGEL, Inc. (“NEXGEL...
2023-03-24 08:11:09 ET Dermata Therapeutics ( DRMA ) +23% . Pyxis Oncology ( PYXS ) +13% . NEXGEL ( NXGL ) +10% . ADMA Biologics ( ADMA ) +8% Q4 earnings call release Heron Therapeutics ( HRTX ) +7% Q4 earnings call release K...
Management will host a conference call at 4:30 P . M . ET on the same day LANGHORNE, Pa., March 15, 2023 (GLOBE NEWSWIRE) -- NEXGEL, Inc. (“NEXGEL” or the “Company”) (NASDAQ: “NXGL”), a leading p...
Gurenlian and his training camp to use NEXGEL’s Turfguard for turf burn in lacrosse LANGHORNE, Pa., March 07, 2023 (GLOBE NEWSWIRE) -- NEXGEL, Inc. (NASDAQ: NXGL, NXGLW), (“NEXGEL” or the “Company”), a leading provider o...
NEXGEL ( NASDAQ: NXGL ) said Thursday it bought 50% interest in a newly formed joint venture, CG Converting and Packaging, with CG Labs for its converting and packaging business. Shares +8.6% at $1.52. The agreement is effective March 1, 2023. NEXGEL said it will contribut...
Strategic investment in CG Labs’ revenue generating and already profitable business increases NEXGEL’s capacity, improves margins and streamlines supply chain LANGHORNE, Pa., March 02, 2023 (GLOBE NEWSWIRE) -- NEXGEL, Inc. (NASDAQ: NXGL, N...
NEXGEL Appoints Scott Henry, CFA to Board of Directors and Audit Committee PR Newswire LANGHORNE, Pa. , Jan. 17, 2023 /PRNewswire/ -- NEXGEL, Inc. (NASDAQ: NXGL, NXGLW), ("NEXGEL" or the "Company"), a leading provider of ultra-gentle, high-water-cont...
LANGHORNE, Pa., Dec. 08, 2022 (GLOBE NEWSWIRE) -- NEXGEL, Inc . (NASDAQ: NXGL, NXGLW), (“NEXGEL” or the “Company”), a leading provider of ultra-gentle, high-water-content hydrogel products for healthcare and consumer applications, announced today that...
The board of the hydrogel products provider NEXGEL ( NASDAQ: NXGL ) has approved a share repurchase program, effective immediately. The company is authorized to purchase up to $500K of shares. The repurchases will be made in the open market. Source: Press Release For...
NEXGEL Announces Share Repurchase Program PR Newswire LANGHORNE, Pa. , Dec. 7, 2022 /PRNewswire/ -- NEXGEL, Inc. ("NEXGEL" or the "Company") (NASDAQ: NXGL, NXGLW), a leading provider of ultra-gentle, high-water-content hydrogel products for healthcar...
News, Short Squeeze, Breakout and More Instantly...
LANGHORNE, Pa., July 08, 2024 (GLOBE NEWSWIRE) -- NEXGEL, Inc. (“NEXGEL” or the “Company”) (NASDAQ: NXGL), a leading provider of medical and over-the-counter (OTC) products including ultra-gentle, high-water-content hydrogels for healthcare and consumer applications,...
LANGHORNE, Pa., June 27, 2024 (GLOBE NEWSWIRE) -- NEXGEL, Inc. (“NEXGEL” or the “Company”) (NASDAQ: NXGL), a leading provider of medical and over-the-counter (OTC) products including ultra-gentle, high-water-content hydrogels for healthcare and consumer applications,...
LANGHORNE, Pa., June 11, 2024 (GLOBE NEWSWIRE) -- NEXGEL, Inc. (“NEXGEL” or the “Company”) (NASDAQ: NXGL), a leading provider of medical and over-the-counter (OTC) products including ultra-gentle, high-water-content hydrogels for healthcare and consumer applications,...